JPRN-UMIN000001049已完成2 期
Adjuvant chemotherapy for completely rsected non-small cell lung cancer with TS-1 - evaluation of predictive factors for prognosis - KOLK-2
Division of General Thoracic Surgery, Keio University, School of Medicine,0 个研究点目标入组 200 人开始时间: 2008年2月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with interstitial change or fobrotic change on chest X ray film or chest CT scan 2) massive pleural effusion or ascites 3) with active double cancer 4) with intractable angina pectoris, myocardial infarction, cardiac failure, intractable diabetes mellitus, hypertension, sever infection, ileus, SVC syndrome, abnormal coagulability 5) watery diarrhea 6) pregnant, nursing woman or woman who is likely to be pregnant 7) men with partner willing to get pregnant 8) with severe drug allergy 9) with hypersensitivity to elements of TS-1 10) under medication with 5-FU 11) under medication with Flucytocine 12) doctor's decision not to be registered to this study
研究者
相似试验
已完成
不适用
To adjuvant chemotherapy after curative treatment of head and neck cancer A study of alternate-day administration definitive TS-1Head and neck cancerJPRN-UMIN000009856ational Center for Global health and Medicine Otolarygology55
招募中
不适用
Outcome of patients treated with chemotherapy and Radiation in Cervical Cancer.CTRI/2014/06/004699A50
招募中
2 期
Neoadjuvant Chemotherapy followed by Pre-operative Chemoradiation and Consolidation Chemotherapy before Surgery in High Risk Rectal Cancer: Multicentric Phase II Study2024-517183-31-00Centro Di Riferimento Oncologico Di Aviano93
尚未招募
3 期
Adjuvant chemotherapy for prevention of recurrence in patients with detectable ctDNA after surgery in high-risk rectal cancer.rectal cancer. rectal carcinoma.10017991NL-OMON56933Erasmus MC, Universitair Medisch Centrum Rotterdam206
进行中（未招募）
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224